ENTITY

Caliway Biopharmaceuticals (6919 TT)

12
Analysis
Health CareTaiwan
Caliway Biopharmaceuticals Co., Ltd. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small molecule therapeutics. The Company develops CBL-514 to treat subcutaneous fat. Caliway Biopharmaceuticals conducts businesses across worldwide.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x